Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: An international comparison

Diabetic Medicine

Volumn 32, Issue 8, 2015, Pages 1036-1050

  Mcknight, J A ^a   Wild, S H ^a   Lamb, M J E ^a   Cooper, M N ^b,c   Jones, T W ^b,c,d   Davis, E A ^b,c,d   Hofer, S ^e   Fritsch, M ^f   Schober, E ^f   Svensson, J ^g   Almdal, T ^h   Young, R ⁱ   Warner, J T ^j   Delemer, B ^k   Souchon, P F ^k   Holl, R W ^l   Karges, W ^m   Kieninger, D M ⁿ   Tigas, S ^o   Bargiota, A ^p   Sampanis, C ^q   Cherubini, V ^r   Gesuita, R ^s   Strele, I ^t   Pildava, S ^u   Coppell, K J ^v   Magee, G ^w   Cooper, J G ^x   Dinneen, S F ^y,z   Eeg Olofsson, K ^aa   Svensson, A M ^ab   Gudbjornsdottir, S ^aa,ab   Veeze, H ^ac   Aanstoot, H J ^ac   Khalangot, M ^ad   Tamborlane, W V ^ae   Miller, K M ^af   on behalf of the a Scottish Diabetes Research Network Epidemiology Group, ^r   German/Austria DPV database, ^r   National Pediatric Diabetes Audit and the Royal College of Paediatrics, ^r   CARe DIAB Network, ^r   RIDI Study Group, ^r   Galway University Hospitals Department of Diabetes Endocrinology and Metabolism, ^r   National Diabetes Register in Sweden, ^r   Ukrainian Diabetes Register Team, ^r   T1D Exchange Clinic Network, ^r   more..

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^h Copenhagen University Hospital ^*  (Denmark)

ⁱ SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^j CHILDREN S HOSPITAL FOR WALES   (United Kingdom)

^k AMERICAN MEMORIAL HOSPITAL   (France)

^l UNIVERSITY OF ULM   (Germany)

^m RWTH AACHEN UNIVERSITY   (Germany)

ⁿ UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^o UNIVERSITY OF IOANNINA   (Greece)

^p UNIVERSITY OF THESSALY   (Greece)

^q ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^r SalesiHospital ^*

^s UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^t RIGA STRADINS UNIVERSITY   (Latvia)

^u Centre for Disease Prevention and Control   (Latvia)

^v UNIVERSITY OF OTAGO   (New Zealand)

^w DAISY HILL HOSPITAL   (United Kingdom)

^x Norwegian Adult Diabetes Register   (Norway)

^y UNIVERSITY HOSPITAL GALWAY   (Ireland)

^z NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^aa SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^ab Center of Registers in Region Vastra Götaland   (Sweden)

^ac Center for Pediatric and Adolescent Diabetes Care and Research   (Netherlands)

^ad SHUPYK NATIONAL MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Ukraine)

^ae YALE UNIVERSITY   (United States)

^af Jaeb Center for Health Sciences Research   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL PRACTICE; DIABETIC PATIENT; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; SAMPLE SIZE; SEX DIFFERENCE; AUSTRALIA; AUSTRIA; COMPARATIVE STUDY; DENMARK; DIABETES MELLITUS, TYPE 1; FRANCE; GERMANY; GREECE; INSULIN INFUSION; IRELAND; ITALY; LATVIA; METABOLISM; NETHERLANDS; NEW ZEALAND; NORWAY; PRACTICE GUIDELINE; REGISTER; SWEDEN; UKRAINE; UNITED KINGDOM; UNITED STATES; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AUSTRIA; DENMARK; DIABETES MELLITUS, TYPE 1; ENGLAND; FEMALE; FRANCE; GERMANY; GREECE; GUIDELINE ADHERENCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; IRELAND; ITALY; LATVIA; MALE; NETHERLANDS; NEW ZEALAND; NORTHERN IRELAND; NORWAY; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; SCOTLAND; SWEDEN; UKRAINE; UNITED STATES; WALES; WESTERN AUSTRALIA; YOUNG ADULT;

EID: 84948716018     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12676     Document Type: Article

References (19)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
2. The Diabetes Control and Complications Trial/Epidemiology of Diabetes. Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000; 342: 381-389.
3. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-2653.
4. Scottish Intercollegiate Guidelines Network. Management of Diabetes: A National Clinical Guideline. Edinburgh: Scottish Intercollegiate Guidelines Network, 2010. Report No. 116.
5. Standards of medical care in diabetes-2013. Diabetes Care 2013; 36(Suppl. 1): S11-S66.
6. IDF/ISPAD. 2011 Global Guideline for Diabetes in Childhood and Adolescence. Available at https://www.ispad.org/resource-type/idfispad-2011-global-guideline-diabetes-childhood-and-adolescence Last accessed 1 December 2013.
7. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002 October 5; 325: 746.
8. Mortensen HB, Hougaard P. Comparison of metabolic control in a cross-sectional study of 2, 873 children and adolescents with IDDM from 18 countries. The Hvidøre Study Group on Childhood Diabetes. Diabetes Care 1997; 20: 714-720.
9. Mortensen HB, Robertson KJ, Aanstoot HJ, Danne T, Holl RW, Hougaard P et al. Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes. Diabet Med 1998; 15: 752-759.
10. Hanberger L, Samuelsson U, Lindblad B, Ludvigsson J. A1C in children and adolescents with diabetes in relation to certain clinical parameters: the Swedish Childhood Diabetes Registry SWEDIABKIDS. Diabetes Care 2008; 31: 927-929.
11. Craig ME, Jones TW, Silink M, Ping YJ. Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region. J Diabetes Complications 2007; 21: 280-287.
12. Wood JR, Miller KM, Maahs DM, Beck RW, DiMeglio LA, Libman IM et al. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care 2013; 36: 2035-2037.
13. Rosenbauer J, Dost A, Karges B, Hungele A, Stahl A, Bachle C et al. Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria. Diabetes Care 2012; 35: 80-86.
14. The EURODIAB IDDM Complications Study Group. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994; 37: 278-285.
15. Lyons SK, Libman IM, Sperling MA. Diabetes in the adolescent: transitional issues. J Clin Endocrinol Metab 2013; 98: 4639-4645.
16. de Beaufort CE, Swift PG, Skinner CT, Aanstoot HJ, Aman J, Cameron F et al. Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidøre Study Group on Childhood Diabetes. Diabetes Care 2007; 30: 2245-2250.
17. Danne T, Mortensen HB, Hougaard P, Lynggaard H, Aanstoot HJ, Chiarelli F et al. Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3, 805 children and adolescents with type 1 diabetes from the Hvidøre Study Group. Diabetes Care 2001; 24: 1342-1347.
18. McKnight JA, Morris AD, Cline D, Peden N, Fischbacher C, Wild S. Implementing a national quality assurance system for diabetes care: the Scottish Diabetes Survey 2001-2006. Diabet Med 2008; 25: 743-746.
19. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA. The T1D Exchange clinic registry. J Clin Endocrinol Metab 2012; 97: 4383-4389.